U-Blot® Research Grade Anti-Human CD19 (VB119)Cat. No. WA1372Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD19 (VB119)Cat. No. WA1372
U-Blot® Research Grade Anti-Human CD19 (UCART19)Cat. No. WA1371
U-Blot® Research Grade Anti-Human CD19 (SGN-CD19B)Cat. No. WA1370
U-Blot® Research Grade Anti-Human CD19 (RD126)Cat. No. WA1369
U-Blot® Research Grade Anti-Human CD19 (RC58)Cat. No. WA1368
U-Blot® Research Grade Anti-Human CD19 (PZ01)Cat. No. WA1367
U-Blot® Research Grade Anti-Human CD19 (PCAR-019)Cat. No. WA1366
U-Blot® Research Grade Anti-Human CD19 (NKX019)Cat. No. WA1365
U-Blot® Research Grade Anti-Human CD19 (JCAR014)Cat. No. WA1364
U-Blot® Research Grade Anti-Human CD19 (IKS03)Cat. No. WA1363
U-Blot® Research Grade Anti-Human CD19 (huB4-DGN462)Cat. No. WA1362
U-Blot® Research Grade Anti-Human CD19 (hA19)Cat. No. WA1361